Coronavirus Vaccine being developed by Oxford University and Astrazeneca shows positive results in their human trials.
The early stage trial has found that the vaccine neutralizing antibodies are produced — molecules which are key to blocking infection. In addition, the vaccine also causes a reaction in the body’s T-cells which help to fight off the coronavirus.
“We are seeing good immune response in almost everybody,” said Dr. Adrian Hill, director of the Jenner Institute at Oxford University. “What this vaccine does particularly well is trigger both arms of the immune system,” he said.
“However, we need more research before we can confirm the vaccine effectively protects against SARS-CoV-2 (COVID-19) infection, and for how long any protection lasts,” he said.
Astrazeneca has also joined hands with Serum Institute in India and will start Human trial in August 2020 in India.